AgeX Therapeutics Inc (AGE) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
AgeX has utilized $500,000 from its credit line provided by Juvenescence, with the repayment of the principal sum scheduled for May 9, 2024. This financial move and its conditions are detailed in AgeX’s recent Quarterly Report submitted to the SEC.
For further insights into AGE stock, check out TipRanks’ Stock Analysis page.